Authors: HEALY DP DANSEREAU RJ DUNN AB CLENDENING CE MOUNTS AW DEEPE GS

Citation: Dp. Healy et al., REDUCED TETRACYCLINE BIOAVAILABILITY CAUSED BY MAGNESIUM ALUMINUM SILICATE IN LIQUID FORMULATIONS OF BISMUTH SUBSALICYLATE, The Annals of pharmacotherapy, 31(12), 1997, pp. 1460-1464

Authors: DANSEREAU RN DANSEREAU RJ LINE BR HEALY D BEKKER P

Citation: Rn. Dansereau et al., A PHARMACO-SCINTIGRAPHY STUDY OF RIBOFLAVIN 5'-PHOSPHATE SODIUM CAPSULES (1 VS 4), International journal of pharmaceutics, 153(2), 1997, pp. 159-166

Authors: DANSEREAU RJ WORTHEN DB

Citation: Rj. Dansereau et Db. Worthen, UNTITLED, International journal of pharmaceutics, 103(1), 1994, pp. 97-97

Authors: BROCK MH DANSEREAU RJ PATEL VS

Citation: Mh. Brock et al., USE OF IN-VITRO AND IN-VIVO DATA IN THE DESIGN, DEVELOPMENT, AND QUALITY-CONTROL OF SUSTAINED-RELEASE DECONGESTANT DOSAGE FORMS, Pharmacotherapy, 14(4), 1994, pp. 430-437

Authors: PERKINS AC WILSON CG BLACKSHAW PE VINCENT RM DANSEREAU RJ JUHLIN KD BEKKER PJ SPILLER RC

Citation: Ac. Perkins et al., IMPAIRED ESOPHAGEAL TRANSIT OF CAPSULE VERSUS TABLET FORMULATIONS IN THE ELDERLY, Gut, 35(10), 1994, pp. 1363-1367

Authors: DANSEREAU RN DANSEREAU RJ STELLA M

Citation: Rn. Dansereau et al., LACK OF LEAD CONTAMINATION OF INJECTABLE SOLUTIONS DURING SIMULATED COMPOUNDING AND DISPENSING OF RADIOPHARMACEUTICALS, American journal of hospital pharmacy, 51(14), 1994, pp. 1800-1802